Real-time fMRI Neurofeedback in Patients With MCI
Targeting Hippocampal Hyperactivity With Real-time Functional MRI Based Neurofeedback in Elderly Individuals With and Without Memory Problems
1 other identifier
interventional
84
1 country
2
Brief Summary
Increased activity in the hippocampus (i.e., hyperactivity) during a fMRI memory task was found in patients with Mild Cognitive Impairment due to Alzheimer's disease (MCI). Those with increased hippocampal activity exhibited elevated clinical progression. Reducing hippocampal hyperactivity with pharmacological treatment reduced hyperactivity and improved memory performance. The investigators of this study will test whether real-time fMRI neurofeedback will also downregulate hippocampal activity and thereby improve memory performance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2020
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 4, 2019
CompletedFirst Posted
Study publicly available on registry
July 16, 2019
CompletedStudy Start
First participant enrolled
July 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2024
CompletedMay 8, 2024
May 1, 2024
3.3 years
July 4, 2019
May 7, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Rate of change in hippocampal activity during a memory task
Measured by fMRI (rate of change in activity from baseline to after the intervention)
Directly after the intervention
Secondary Outcomes (2)
Rate of change in memory performance
Directly after the intervention
Rate of change from in memory performance (behavioural)
Directly after the intervention
Other Outcomes (2)
Strategies for Regulation of hippocampal activity
Intervention
Predictors of neurofeedback success
Post-Intervention
Study Arms (4)
healthy elderly participants receiving feedback from the hippocampus
ACTIVE COMPARATORThis group will consist of healthy elderly volunteers, who will receive feedback from their hippocampal activity.
healthy elderly participants receiving feedback from another area
SHAM COMPARATORThis group will consist of healthy elderly volunteers, who will receive feedback from another brain area.
patients with MCI receiving feedback from the hippocampus
EXPERIMENTALThis group will consist of patients with mild cognitive impairment, who will receive feedback from their hippocampal activity.
patients with MCI receiving feedback from another brain area
SHAM COMPARATORThis group will consist of patients with mild cognitive impairment, who will receive feedback from another brain area.
Interventions
During real-time fMRI neurofeedback, participants are trained to 'control' hippocampal activity. The training is accomplished by continuously measuring brain activity, analysing it in real-time, and then providing feedback about the current (and the targeted) brain activity to the participant.
During real-time fMRI neurofeedback, participants are trained to 'control' hippocampal activity. The training is accomplished by continuously measuring brain activity, analysing it in real-time, and then providing feedback about the current (and the targeted) brain activity to the participant.
Eligibility Criteria
You may qualify if:
- Intact activities of daily living
- Fluent in German
- Normal/corrected-to-normal vision
- Written informed consent
You may not qualify if:
- Dementia
- Current/lifetime severe psychiatric or neurological disorder
- History of seizures
- Psychotropic medication
- Currently/lifetime drug or alcohol abuse
- Brain damage
- Magnetisable implants
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Bernlead
- University of Zurichcollaborator
Study Sites (2)
SITEM (Swiss Institute for Translational and Entrepreneurial Medicine)
Bern, 3010, Switzerland
University of Zurich
Zurich, 8092, Switzerland
Related Publications (1)
Klink K, Jaun U, Federspiel A, Wunderlin M, Teunissen CE, Kiefer C, Wiest R, Scharnowski F, Sladky R, Haugg A, Hellrung L, Peter J. Targeting hippocampal hyperactivity with real-time fMRI neurofeedback: protocol of a single-blind randomized controlled trial in mild cognitive impairment. BMC Psychiatry. 2021 Feb 9;21(1):87. doi: 10.1186/s12888-021-03091-8.
PMID: 33563242DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jessica Peter, PD Dr.
University of Bern
- PRINCIPAL INVESTIGATOR
Stefan Klöppel, Prof. Dr.
University of Bern
- STUDY CHAIR
Frank Scharnowski, Prof. Dr.
University of Vienna
- STUDY CHAIR
Roland Wiest, Prof. Dr.
University of Bern
- STUDY CHAIR
Katharina Klink
University of Bern
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- For blinding of the participants, they will be told that they will be asked to regulate one of two brain regions, without mentioning the specific area.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 4, 2019
First Posted
July 16, 2019
Study Start
July 1, 2020
Primary Completion
October 31, 2023
Study Completion
January 31, 2024
Last Updated
May 8, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share